APA (7th ed.) Citation

IM, M., M, M., X, C., H, L., L, L., J, W., . . . JA, R. (2018). TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models. Cancer immunology research, 6(2), 163. https://doi.org/10.1158/2326-6066.CIR-17-0273

Chicago Style (17th ed.) Citation

IM, Meraz, et al. "TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 Through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models." Cancer Immunology Research 6, no. 2 (2018): 163. https://doi.org/10.1158/2326-6066.CIR-17-0273.

MLA (9th ed.) Citation

IM, Meraz, et al. "TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 Through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models." Cancer Immunology Research, vol. 6, no. 2, 2018, p. 163, https://doi.org/10.1158/2326-6066.CIR-17-0273.